Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Fantini

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 21, 2016
Telephonic voice intelligibility after laryngeal cancer treatment: is therapeutic approach significant?Erika Crosetti, Marco Fantini, Giulia Arrigoni, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNa(v)1.2Mirko Rivara, Aparna R Baheti, Marco Fantini, et al.
Chemistry & Biodiversity|January 22, 2008
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptorMirko Rivara, Federica Vacondio, Claudia Silva, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Open Partial Horizontal Laryngectomy as a Conservative Salvage Treatment for Laser-Recurrent Laryngeal Cancer: A Multi-Institutional SeriesErika Crosetti, Andrea Borello, Andy Bertolin, et al.
European Journal of Medicinal Chemistry|March 10, 2009
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell lineValentina Zuliani, Caterina Carmi, Mirko Rivara, et al.
Cancers|June 22, 2023
Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected CasesGiovanni Succo, Andy Bertolin, Izabela Costa Santos, et al.
Bioorganic & Medicinal Chemistry|April 28, 2009
2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationshipsMarco Fantini, Mirko Rivara, Valentina Zuliani, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 21, 2016
Telephonic voice intelligibility after laryngeal cancer treatment: is therapeutic approach significant?Erika Crosetti, Marco Fantini, Giulia Arrigoni, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
2,4(5)-Diarylimidazoles: synthesis and biological evaluation of a new class of sodium channel blockers against hNa(v)1.2Mirko Rivara, Aparna R Baheti, Marco Fantini, et al.
Chemistry & Biodiversity|January 22, 2008
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptorMirko Rivara, Federica Vacondio, Claudia Silva, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Open Partial Horizontal Laryngectomy as a Conservative Salvage Treatment for Laser-Recurrent Laryngeal Cancer: A Multi-Institutional SeriesErika Crosetti, Andrea Borello, Andy Bertolin, et al.
European Journal of Medicinal Chemistry|March 10, 2009
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell lineValentina Zuliani, Caterina Carmi, Mirko Rivara, et al.
Cancers|June 22, 2023
Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected CasesGiovanni Succo, Andy Bertolin, Izabela Costa Santos, et al.
Bioorganic & Medicinal Chemistry|April 28, 2009
2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationshipsMarco Fantini, Mirko Rivara, Valentina Zuliani, et al.
Pageof 6